| 促红细胞生成素与心血管疾病 |
| |
| 引用本文： | 赵玉伟,李法琦. 促红细胞生成素与心血管疾病[J]. 心血管病学进展, 2006, 27(1): 41-44 |
| |
| 作者姓名： | 赵玉伟 李法琦 |
| |
| 作者单位： | 重庆医科大学附属第一医院心内科,重庆,400016 |
| |
| 摘 要： | 新近研究认为促红细胞生成素是一作用广泛的细胞保护剂,体内许多器官和组织包括心脏都表达促红细胞生成素及其受体,它可以减轻缺血缺氧时心肌细胞的损伤,减少心肌细胞的凋亡和促进新生血管生成,从而使其可能成为心血管疾病的治疗方法。
|
| 关 键 词： | 促红细胞生成素 心血管疾病 细胞凋亡 |
| 文章编号： | 1004-3934(2006)01-0041-04 |
| 收稿时间： | 2005-07-05 |
| 修稿时间： | 2005-07-05 |
Erythropoietin and Cardiovascular Diseases |
| |
| ZHAO Yu-wei,LI Fa-qi. Erythropoietin and Cardiovascular Diseases[J]. Advances in Cardiovascular Diseases, 2006, 27(1): 41-44 |
| |
| Authors: | ZHAO Yu-wei LI Fa-qi |
| |
| Affiliation: | Department of Cardiology, The First Affiliated Hospital of Chongqing University of Medical Science, Chongqing 400016, China |
| |
| Abstract: | Recent studies have demonstrated that erythropoietin is a broad cytoprotective agent.Many organs and tissues including heart express erythropoietin and its receptor.When myocardial tissue is subjected to hypoxia/ ischemia stress,it can mitigate cell damage,reduce apoptosis and promote angiogenesis.As a result,erythropoietin has been identified as a possible candidate in the therapeutic strategies for cardiovascular diseases. |
| |
| Keywords: | erythropoietin cardiovascular diseases apoptosis |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
